retatrutide prescribing information reconstitution Dosing Guide for Researchers Retatrutide Product Information & Safety

Weight changes were modest, typically between a 2 to 6 pound loss over six months

Additionally, GLP-1 therapies suppress glucagon, a hormone that normally elevates blood sugar, further enhancing glucose regulation

When blood glucose rises, insulin release increases

Commonly reported retatrutide side effects in trials include: Nausea (especially during dose increases) Vomiting Diarrhoea or constipation Abdominal pain or bloating Indigestion / reflux Injection-site reactions or hypersensitivity in some people So far, hair loss has not been listed as a common, direct side effect of retatrutide in clinical trial publications

One of the factors playing into this new market is social media- and influencer-driven consumer demand

FOR VOMITING SOURCE: MedlinePlus